-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Xylem, Raises Price Target to $138

Benzinga·08/13/2026 20:53:10
Listen to the news
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $135 to $138.